Psychiatry

Screenings for ADHD have not improved in several years.

Medications in psychiatry are often ineffective for patients.

Only 29.5% of sampled CBD users claimed any wellness benefit.

Dr. Cortese discusses how new research can drive changes to ADHD clinical trials.

The younger generation is able to adapt to new technology for therapy better than previous generations.

Cataracts, but not AMD or glaucoma, were associated with an increased risk of depressive symptoms in the elderly in a prospective long-term study.

The schizophrenia drug currently has a PDUFA date set for November 15.

The Arbor Pharmaceutical drug is aimed at treating ADHD without being manipulated for non-oral use.

ELP Pharma readying plans to continue to study the drug in a phase 3 trial.

There was also a decline depression care in recent years among adolescents and young adults.

A virtual reality platform could enable ADHD patients to improve cognitive functioning.

Paul Christo, MD, discusses opioid addiction during the pandemic, the role of the clinician, and offers a hopeful outlook for the future.

Experts expect an increase in mental health issues caused by the pandemic in the future.

Medication might be best used as a first-line option for patients with ADHD.

An expert discusses trends in pediatric mental health and receipt of treatment.

Higher levels of acetaminophen detected in meconium was linked to increased odds of developing ADHD by 6-7 years old.

There could be a lasting impact caused by some of the changes due to the pandemic.

This edition from the 10 Year Plan features perspective from leadership at APA and AADPRT, as well as survey results from psychiatrists.

These disparities were noted between age groups, sex, race/ethnicity, and urbanization level of residence.

For many patients suffering from depression or anxiety, the added stress of the pandemic has led to a medication change.

Because ADHD presents differently in females than it does in males, the disorder has been underdiagnosed in females for several years.

Dr. Cerulli discusses some ways ADHD can manage the changes in routine during COVID-19.

Investigators did not find differences between children with ASD and children with ADHD after accounting for task behavior durations as percentages of total used task time.

Phthalates were particularly linked to negative behaviors in adolescents who developed ADHD.

Data shows certain personality traits are linked to a COPD patient's likelihood of active or sedentary behaviors.